No black box warning on record for Sodium Sulfacetamide, Sulfur

As of the latest FDA labeling reviewed, Sodium Sulfacetamide, Sulfur (SODIUM SULFACETAMIDE 8% SULFUR 4%) does not carry a black box warning. Standard warnings and precautions still apply — see the full Sodium Sulfacetamide, Sulfur medicine page for the complete safety profile.

Other warnings & precautions

Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfo

No black box warning on record for Sodium Sulfacetamide, Sulfur

Other warnings & precautions

Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfo

Sodium Sulfacetamide, Sulfur Black Box Warning

No black box warning on record for Sodium Sulfacetamide, Sulfur

Other warnings & precautions

Sodium Sulfacetamide, Sulfur Black Box Warning

No black box warning on record for Sodium Sulfacetamide, Sulfur

Other warnings & precautions